Medicus Pharma Ltd.
MDCX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.92M | 14.94M | 11.69M | 9.39M | 7.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.64M | 21.44M | 17.06M | 14.60M | 11.18M |
| Operating Income | -25.64M | -21.44M | -17.06M | -14.60M | -11.18M |
| Income Before Tax | -47.28M | -35.75M | -17.09M | -14.55M | -11.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.28 | -35.75 | -17.09 | -14.55 | -11.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 200.00 | 100.00 | -- | -- | -- |
| Net Income | -47.28M | -35.75M | -17.09M | -14.55M | -11.16M |
| EBIT | -25.64M | -21.44M | -17.06M | -14.60M | -11.18M |
| EBITDA | -- | -3.56M | -5.87M | -9.39M | -11.15M |
| EPS Basic | -2.78 | -2.28 | -1.40 | -1.41 | -1.21 |
| Normalized Basic EPS | -1.42 | -1.11 | -0.87 | -0.88 | -0.75 |
| EPS Diluted | -3.60 | -2.28 | -1.40 | -1.41 | -1.21 |
| Normalized Diluted EPS | -1.42 | -1.11 | -0.87 | -0.88 | -0.75 |
| Average Basic Shares Outstanding | 63.76M | 56.52M | 47.40M | 41.29M | 37.12M |
| Average Diluted Shares Outstanding | 63.76M | 56.52M | 47.40M | 41.29M | 37.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |